Trial intelligence / Profile preview

Terminalia chebula gel for pain reduction in knee osteoarthritis

IRCT20240406061427N1Phase 3Completed

Sponsor
Shahrekord University of Medical Sciences
Start
Jul 2024
Countries
1
01

Overview

Phase 3 trial of terminalia chebula in knee osteoarthritis (OA), sponsored by Shahrekord University of Medical Sciences. Started Jul 2024; status: completed.

02

Drugs

terminalia chebula
03

Conditions

knee osteoarthritis (OA)

Beyond the preview

Go deeper on IRCT20240406061427N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20240406061427N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call